EP Patent

EP1316203A2 — Combination for treating psychoses, comprising an antipsychotic and a muscarinic agonist

Assigned to Eli Lilly and Co · Expires 2003-06-04 · 23y expired

What this patent protects

The invention provides combination therapy comprising a first component which is a typical antipsychotic or an atypical antipsychotic and a second component which is a muscarinic agonist for the treatment of psychoses and other disorders.

USPTO Abstract

The invention provides combination therapy comprising a first component which is a typical antipsychotic or an atypical antipsychotic and a second component which is a muscarinic agonist for the treatment of psychoses and other disorders.

Drugs covered by this patent

Patent Metadata

Patent number: EP1316203A2
Jurisdiction: EP
Classification: —
Expires: 2003-06-04
Drug substance claim: No
Drug product claim: No
Assignee: Eli Lilly and Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.